Lixte Biotechnology

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell LIXT and other ETFs, options, and stocks.

About LIXT

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets and designs novel compounds to attack those targets.

CEO

John S. Kovach

CEOJohn S. Kovach

Employees

Employees4

Headquarters

Pasadena, California

HeadquartersPasadena, California

Founded

2005

Founded2005

Employees

Employees4

LIXT Key Statistics

Market cap

9.36M

Market cap9.36M

Price-Earnings ratio

—

Price-Earnings ratio—

Dividend yield

—

Dividend yield—

Average volume

46.24K

Average volume46.24K

High today

$0.60

High today$0.60

Low today

$0.562

Low today$0.562

Open price

$0.60

Open price$0.60

Volume

9.91K

Volume9.91K

52 Week high

$4.95

52 Week high$4.95

52 Week low

$0.432

52 Week low$0.432

LIXT Earnings

-$0.15

-$0.10

-$0.05

$0.00

Q1 FY21

Q2 FY21

Q3 FY21

Q4 FY21

Q1 FY22

Q2 FY22

Q3 FY22

Estimated

— per share

Estimated— per share

Actual

Expected Nov 9, Pre-Market

ActualExpected Nov 9, Pre-Market

Lixte Biotechnology

Why Robinhood?

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets and designs novel compounds to attack those targets. Show more

LIXT Key Statistics

Lixte Biotechnology Holdings, Inc. operates as a drug discovery company. It uses biomarker technology to identify enzyme targets and designs novel compounds to attack those targets.